GLIVEC for Gastrointestinal neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 61 adverse event reports in the FDA FAERS database where GLIVEC was used for Gastrointestinal neoplasm.
Most Reported Side Effects for GLIVEC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 628 | 63.1% | 628 | 14 |
| Malignant neoplasm progression | 60 | 6.0% | 53 | 12 |
| Gastrointestinal stromal tumour | 40 | 4.0% | 30 | 12 |
| Chronic myeloid leukaemia | 38 | 3.8% | 34 | 6 |
| Anaemia | 30 | 3.0% | 18 | 13 |
| Second primary malignancy | 27 | 2.7% | 5 | 12 |
| Pyrexia | 21 | 2.1% | 16 | 9 |
| Blast crisis in myelogenous leukaemia | 20 | 2.0% | 20 | 3 |
| Dyspnoea | 19 | 1.9% | 14 | 9 |
| Malaise | 16 | 1.6% | 7 | 6 |
| Thrombocytopenia | 16 | 1.6% | 10 | 5 |
| Vomiting | 16 | 1.6% | 9 | 11 |
| Diarrhoea | 15 | 1.5% | 6 | 8 |
| General physical health deterioration | 15 | 1.5% | 13 | 8 |
| Nausea | 15 | 1.5% | 10 | 8 |
Other Indications for GLIVEC
Chronic myeloid leukaemia (636)
Gastrointestinal stromal tumour (231)
Acute lymphocytic leukaemia (61)
Chromosome analysis abnormal (14)
Acute myeloid leukaemia (10)
Off label use (6)
Other Drugs Used for Gastrointestinal neoplasm
IMATINIB (81)
OXALIPLATIN (64)
FLUOROURACIL (32)
NIVOLUMAB (23)
LEUCOVORIN (19)
CAPECITABINE (18)
SUNITINIB MALATE (18)
OCTREOTIDE (15)
TELOTRISTAT ETHYL (13)
BEVACIZUMAB (8)